MX9802891A - Antibioticos de cefalosporina. - Google Patents

Antibioticos de cefalosporina.

Info

Publication number
MX9802891A
MX9802891A MX9802891A MX9802891A MX9802891A MX 9802891 A MX9802891 A MX 9802891A MX 9802891 A MX9802891 A MX 9802891A MX 9802891 A MX9802891 A MX 9802891A MX 9802891 A MX9802891 A MX 9802891A
Authority
MX
Mexico
Prior art keywords
novel
compounds
present
useful
cephalosporin antibiotics
Prior art date
Application number
MX9802891A
Other languages
English (en)
Inventor
In-Seop Cho
Scott Hecker
Tomasz Glinka
Ving J Lee
Zhijia J Zhang
Original Assignee
Microcide Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microcide Pharmaceuticals Inc filed Critical Microcide Pharmaceuticals Inc
Publication of MX9802891A publication Critical patent/MX9802891A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/59Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with hetero atoms directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

La presente invencion incluye ácidos (7R)-7-(acilamino)-3-(ariltio)-3-cafem-4-carboxíli cos o sus sales farmacologicamente aceptables, que exhiben actividad antibiotica contra un gran espectro de organismos, incluyendo organismos resistentes a los antibioticos beta-lactámicos, y son utiles como agentes antibacterianos; la invencion también se refiere a intermediarios novedosos utiles para producir los compuestos nuevos de la presente invencion y a métodos novedosos para producir los compuestos nuevos y los compuestos intermediarios.
MX9802891A 1995-10-12 1998-04-13 Antibioticos de cefalosporina. MX9802891A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US538995P 1995-10-12 1995-10-12

Publications (1)

Publication Number Publication Date
MX9802891A true MX9802891A (es) 1998-09-30

Family

ID=21715599

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9802891A MX9802891A (es) 1995-10-12 1998-04-13 Antibioticos de cefalosporina.

Country Status (28)

Country Link
US (4) US6066630A (es)
EP (1) EP0874854B1 (es)
JP (1) JPH11513670A (es)
KR (2) KR100455544B1 (es)
CN (3) CN1066735C (es)
AR (1) AR005642A1 (es)
AT (1) ATE210666T1 (es)
AU (1) AU708676B2 (es)
BR (1) BR9611062A (es)
CA (1) CA2234255A1 (es)
CZ (1) CZ108998A3 (es)
DE (1) DE69618015T2 (es)
DK (1) DK0874854T3 (es)
ES (1) ES2164924T3 (es)
HK (3) HK1017887A1 (es)
HU (1) HUP9802545A3 (es)
IL (1) IL123983A (es)
MX (1) MX9802891A (es)
MY (1) MY127641A (es)
NO (1) NO323007B1 (es)
NZ (1) NZ321135A (es)
PL (1) PL192069B1 (es)
PT (1) PT874854E (es)
RO (1) RO119830B1 (es)
SK (1) SK283524B6 (es)
TW (1) TW474935B (es)
WO (1) WO1997013772A2 (es)
ZA (1) ZA968617B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1295935B1 (it) 1997-10-30 1999-05-28 Acs Dobfar Spa Derivati aminotiazolici utili nella preparazione di antibiotici b -lattamici
US6159706A (en) * 1997-12-23 2000-12-12 Newbiotics, Inc. Application of enzyme prodrugs as anti-infective agents
US6723716B1 (en) * 1999-09-22 2004-04-20 Essential Therapeutics, Inc. 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotics and prodrugs thereof
AR029004A1 (es) * 1999-09-22 2003-06-04 Essential Therapeutics Inc Compuesto del acido 7-acilamino-3-heteroariltio-3-cefem carboxilico y su uso para la preparacion de una composicion antibacteriana
CA2409337A1 (en) * 2000-07-07 2002-01-17 Lg Life Sciences Ltd. Novel cephalosporin compounds and process for preparing the same
CN1606558A (zh) * 2000-07-07 2005-04-13 株式会社Lg生命科学 新型头孢菌素化合物及其制备方法
US6599893B2 (en) * 2000-08-29 2003-07-29 Essential Therapeutics, Inc. Cephalosporin antibiotics and prodrugs thereof
AU2001245902B2 (en) * 2000-09-21 2007-08-23 Trine Pharmaceuticals, Inc. Prodrugs of a 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotic
WO2002054743A2 (en) 2000-12-29 2002-07-11 Bellsouth Intellectual Property Corporation Web based messaging system with personalized caller specific messages
US7119062B1 (en) 2001-02-23 2006-10-10 Neucoll, Inc. Methods and compositions for improved articular surgery using collagen
US6608196B2 (en) 2001-05-03 2003-08-19 Galileo Pharmaceuticals, Inc. Process for solid supported synthesis of pyruvate-derived compounds
ATE408593T1 (de) 2001-05-03 2008-10-15 Galileo Lab Inc Pyruvatderivate
KR20030071311A (ko) * 2002-02-28 2003-09-03 주식회사 엘지생명과학 신규 세팔로스포린 화합물 및 그의 제조방법
US7317001B2 (en) * 2002-06-06 2008-01-08 Oscient Pharmaceuticals Corporation Use of ramoplanin to treat diseases associated with the use of antibiotics
AU2003274927A1 (en) * 2002-08-23 2004-03-11 Genome Therapeutics Corporation Methods and reagents for preventing bacteremias
US20050043223A1 (en) * 2003-04-25 2005-02-24 Leach Timothy S. Methods for reducing or preventing transmission of nosocomial pathogens in a health care facility
SG11201707418WA (en) 2015-03-13 2017-10-30 Forma Therapeutics Inc Alpha-cinnamide compounds and compositions as hdac8 inhibitors
AU2017228870B2 (en) 2016-03-07 2021-02-18 Merck Sharp & Dohme Llc Bicyclic aryl monobactam compounds and methods of use thereof for the treatment of bacterial infections
CN114671892B (zh) * 2022-04-24 2023-04-11 江苏海洋大学 含7-氨基头孢烷酸的1,3,4-噻二唑衍生物及制法与用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH605997A5 (es) * 1974-08-30 1978-10-13 Ciba Geigy Ag
US3992377A (en) * 1974-12-13 1976-11-16 Eli Lilly And Company 3-Thio-substituted cephalosporin antibiotics
FR2457297A1 (fr) * 1979-05-23 1980-12-19 Rhone Poulenc Ind Nouvelles vinyl-3 cephalosporines, et leur preparation
CA1145744A (fr) * 1979-05-23 1983-05-03 Daniel Farge Thiovinyl-3 cephalosporines, leur preparation et les compositions qui les contiennent
FR2494274A2 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouvelles thiovinyl-3 cephalosporines, leur preparation et les medicaments qui les contiennent
GR79043B (es) * 1982-12-06 1984-10-02 Fujisawa Pharmaceutical Co
US4870168A (en) * 1987-02-26 1989-09-26 Bristol-Myers Company 3-Unsaturated alkyl cephems from 3-triflyl cephems
US5025006A (en) * 1990-06-26 1991-06-18 Merck & Co., Inc. 2-biphenyl-carbapenem antibacterial agents
US5077287A (en) * 1991-01-18 1991-12-31 Eli Lilly And Company 3-thiazolylthio carbacephem antibacterial agents
JPH05132488A (ja) * 1991-08-13 1993-05-28 Meiji Seika Kaisha Ltd 新規セフアロスポリン誘導体
TW427993B (en) * 1993-09-09 2001-04-01 Fujisawa Pharmaceutical Co New cephem compounds
NZ284212A (en) * 1994-04-01 1997-11-24 Microcide Pharmaceuticals Inc Cephalosporin antibiotics; antibacterial medicament

Also Published As

Publication number Publication date
IL123983A (en) 2007-03-08
HK1034248A1 (en) 2001-10-19
DE69618015T2 (de) 2002-05-16
ZA968617B (en) 1997-10-21
SK283524B6 (sk) 2003-09-11
US6066630A (en) 2000-05-23
NO981653L (no) 1998-06-11
HK1034191A1 (en) 2001-10-19
MY127641A (en) 2006-12-29
NO981653D0 (no) 1998-04-08
HUP9802545A3 (en) 2001-01-29
PT874854E (pt) 2002-06-28
DK0874854T3 (da) 2002-03-25
CN1291612A (zh) 2001-04-18
AU708676B2 (en) 1999-08-12
RO119830B1 (ro) 2005-04-29
AR005642A1 (es) 1999-07-14
TW474935B (en) 2002-02-01
KR100455544B1 (ko) 2005-01-15
BR9611062A (pt) 1999-07-13
CZ108998A3 (cs) 1998-07-15
US6087355A (en) 2000-07-11
DE69618015D1 (de) 2002-01-24
CA2234255A1 (en) 1997-04-17
CN1291611A (zh) 2001-04-18
NZ321135A (en) 2000-01-28
ES2164924T3 (es) 2002-03-01
US5859256A (en) 1999-01-12
CN1066735C (zh) 2001-06-06
EP0874854B1 (en) 2001-12-12
CN1204336A (zh) 1999-01-06
EP0874854A2 (en) 1998-11-04
CN1179963C (zh) 2004-12-15
KR19990064201A (ko) 1999-07-26
WO1997013772A3 (en) 1997-06-05
WO1997013772A2 (en) 1997-04-17
PL326150A1 (en) 1998-08-31
HK1017887A1 (en) 1999-12-03
CN1183142C (zh) 2005-01-05
PL192069B1 (pl) 2006-08-31
JPH11513670A (ja) 1999-11-24
HUP9802545A2 (hu) 1999-05-28
ATE210666T1 (de) 2001-12-15
NO323007B1 (no) 2006-12-18
KR100491466B1 (ko) 2005-05-25
US6057312A (en) 2000-05-02
SK46498A3 (en) 1998-10-07
KR20040047794A (ko) 2004-06-05
AU7441796A (en) 1997-04-30

Similar Documents

Publication Publication Date Title
MX9604505A (es) Antibioticos de cefalosporina.
MX9802891A (es) Antibioticos de cefalosporina.
IE49880B1 (en) Penicillin derivatives
RU93050129A (ru) Новые производные эритромицина, метод их получения и фармацевтическая композиция на их основе и промежуточные соединения синтеза
AU7648898A (en) Process for the fermentative production of deacylated cephalosporins
MX9804046A (es) 6-0-metil eritromicina d y proceso para hacerla.
ES8606360A1 (es) Un derivado de cefalosporina.
NZ308518A (en) Antibacterial cephalosporins
EP0393424A3 (de) Verfahren zur Herstellung von 2,7-Diazabicyclo(3.3.0)octanen
IE850475L (en) 6-(aminoacyloxymethyl) penicillanic acid 1,1-dioxides as beta-lactamase inhibitors
DE69805975D1 (de) 2-beta-substituierte-6-alkylidenpenizillansäure-derivate als beta-laktamase inhibitoren
EP0723966A4 (en) NEW DERIVATIVES FROM CEPHEM
EP0669336A4 (en) NEW CEPHEM DERIVATIVES.
CA2146475A1 (en) Process for the Preparation of Azithromycin Dihydrochloride
AU551236B2 (en) Process for the preparation of 6-bromo-, 6-ronhch2- substituted and 6-unsubstituted penicillins
GB8811873D0 (en) Therapeutic agents
ES8103094A1 (es) Un procedimiento para la preparacion de 1,1-dioxido de acidopenicilanico y esteres del mismo
AU6210790A (en) Novel compounds
CA2002597A1 (en) Solvates of b-lactam antibiotic
FR2356653A1 (fr) Procede de desesterification d'esters d'antibiotiques de b-lactame
CA2284501A1 (en) Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates
AU590142B2 (en) 6-Beta (substituted)-(s)-hydroxymethylpenicillanic acids and derivatives thereof
YU48092A (sh) Postupak za dobijanje dvostruko blokiranih 1 karba(1-delta)-3-cefem-4-karboksilnih kiselina
JPS6422850A (en) 2-alkoxypropionamide derivative and its preparation
TH13040EX (th) คาร์บาพีเนม ซึ่งมีหมู่เฟนิลที่ถูกแทนที่ด้วย หมู่คาร์บอกซิ, กรรมวิธีสำหรับเตรียมสารเหล่านั้น สารขั้นกลางการใช้เป็นสารปฏิชีวนะ

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status

Owner name: GEORGIA TECH RESEARCH CORPORATION.*

MM Annulment or lapse due to non-payment of fees